BioCentury | Nov 30, 2018
Emerging Company Profile

Afyx: Mucosal drug delivery

...Clinical status: Phase II Founded: 2014 by Jens Hansen and Lars Hellerung Christiansen University collaborators: The University of Sheffield...
BioCentury | Nov 16, 2018
Preclinical News

Preventing DNA repair blocks inflammation

...inflammation in the lungs and airways. The Helleday Foundation, founded by author Thomas Helleday of the University of Sheffield...
...expects to start Phase I trials within two years to treat airway inflammation diseases. Sandi Wong Karolinska Institute The University of Sheffield 8-oxoguanine...
BioCentury | Apr 13, 2018
Emerging Company Profile

Reversing Neuropathy

...of Medicine at Mount Sinai, Radboud University Medical Center, University of Leuven, University of Pittsburgh, The University of Sheffield...
BioCentury | Feb 24, 2018
Regulation

Herculean task for DMD

...patients progressing toward loss of ambulation. HERCULES is developing the DMD-focused metric in collaboration with The University of Sheffield’s...
...Cambridge, Mass. Solid Biosciences Inc. (NASDAQ:SLDB), Cambridge, Mass. Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT), Abingdon, U.K. The University of Sheffield...
BioCentury | Jan 12, 2018
Company News

Duchenne UK launches data-sharing collaboration

...Ltd. (NASDAQ:WVE), Cambridge, Mass. Business: Musculoskeletal Mary Romeo Pfizer Inc. PTC Therapeutics Inc. Roche Sarepta Therapeutics Inc. Solid Biosciences LLC Summit Therapeutics plc The University of Sheffield University...
BioCentury | Jan 11, 2018
Company News

Duchenne UK launches data-sharing initiative

...BioCentury Extra, Nov. 3, 2017) . Mary Romeo Pfizer Inc. PTC Therapeutics Inc. Roche Sarepta Therapeutics Inc. Solid Biosciences LLC Summit Therapeutics plc The University of Sheffield University...
BioCentury | Nov 1, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2017

...studies suggest inhibition of C. difficile SlpA could help treat Clostridium infection. AvidBiotics Corp. ; The University of Sheffield...
BioCentury | Oct 5, 2017
Product R&D

Avidly specific

...disrupting the microbiome. In the new Sci. Transl. Med. study, the company and collaborators at The University of Sheffield...
...Kenilworth, N.J. University of California Los Angeles, Los Angeles, Calif. University of Glasgow, Glasgow, U.K. The University of Sheffield...
BioCentury | Dec 16, 2016
Company News

Mironid, University of Sheffield deal

...for publication. Mironid Ltd. , Newhouse, U.K. University of Sheffield, Sheffield, U.K. Business: Renal Alicia Parker Mironid Ltd. The University of Sheffield Phosphodiesterase-4...
BioCentury | Jul 28, 2016
Finance

MRCT looks east

...effort by biologists and data scientists at Columbia University , National Tsing Hua University and the University of Sheffield...
...Waltham, Mass. Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands Taiho Pharmaceutical Co. Ltd., Tokyo, Japan The University of Sheffield...
Items per page:
1 - 10 of 32
BioCentury | Nov 30, 2018
Emerging Company Profile

Afyx: Mucosal drug delivery

...Clinical status: Phase II Founded: 2014 by Jens Hansen and Lars Hellerung Christiansen University collaborators: The University of Sheffield...
BioCentury | Nov 16, 2018
Preclinical News

Preventing DNA repair blocks inflammation

...inflammation in the lungs and airways. The Helleday Foundation, founded by author Thomas Helleday of the University of Sheffield...
...expects to start Phase I trials within two years to treat airway inflammation diseases. Sandi Wong Karolinska Institute The University of Sheffield 8-oxoguanine...
BioCentury | Apr 13, 2018
Emerging Company Profile

Reversing Neuropathy

...of Medicine at Mount Sinai, Radboud University Medical Center, University of Leuven, University of Pittsburgh, The University of Sheffield...
BioCentury | Feb 24, 2018
Regulation

Herculean task for DMD

...patients progressing toward loss of ambulation. HERCULES is developing the DMD-focused metric in collaboration with The University of Sheffield’s...
...Cambridge, Mass. Solid Biosciences Inc. (NASDAQ:SLDB), Cambridge, Mass. Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT), Abingdon, U.K. The University of Sheffield...
BioCentury | Jan 12, 2018
Company News

Duchenne UK launches data-sharing collaboration

...Ltd. (NASDAQ:WVE), Cambridge, Mass. Business: Musculoskeletal Mary Romeo Pfizer Inc. PTC Therapeutics Inc. Roche Sarepta Therapeutics Inc. Solid Biosciences LLC Summit Therapeutics plc The University of Sheffield University...
BioCentury | Jan 11, 2018
Company News

Duchenne UK launches data-sharing initiative

...BioCentury Extra, Nov. 3, 2017) . Mary Romeo Pfizer Inc. PTC Therapeutics Inc. Roche Sarepta Therapeutics Inc. Solid Biosciences LLC Summit Therapeutics plc The University of Sheffield University...
BioCentury | Nov 1, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2017

...studies suggest inhibition of C. difficile SlpA could help treat Clostridium infection. AvidBiotics Corp. ; The University of Sheffield...
BioCentury | Oct 5, 2017
Product R&D

Avidly specific

...disrupting the microbiome. In the new Sci. Transl. Med. study, the company and collaborators at The University of Sheffield...
...Kenilworth, N.J. University of California Los Angeles, Los Angeles, Calif. University of Glasgow, Glasgow, U.K. The University of Sheffield...
BioCentury | Dec 16, 2016
Company News

Mironid, University of Sheffield deal

...for publication. Mironid Ltd. , Newhouse, U.K. University of Sheffield, Sheffield, U.K. Business: Renal Alicia Parker Mironid Ltd. The University of Sheffield Phosphodiesterase-4...
BioCentury | Jul 28, 2016
Finance

MRCT looks east

...effort by biologists and data scientists at Columbia University , National Tsing Hua University and the University of Sheffield...
...Waltham, Mass. Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands Taiho Pharmaceutical Co. Ltd., Tokyo, Japan The University of Sheffield...
Items per page:
1 - 10 of 32